Exhibit 99.1 Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025 San Diego, CA – May 8, 2025 – Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation to optimize health, today reported its three months ended March 31, 2025 financial results. Corporate Highlights "While we continue to expand the pipeline here at Revelation, we are excited to continue our coll ...